Introduction
This article provides a formal corrigendum for the study titled "Initial development of perpetrator confrontation using deepfake technology in victims with sexual violence-related PTSD and moral injury" (originally published under DOI: 10.3389/fpsyt.2022.882957). The primary objective of this update is to rectify an omission in the original "Conflict of Interest" statement, specifically regarding the commercial affiliations of the research team with the technology provider, 3DUniversum.
The Clinical Context: PTSD and Moral Injury
The original research addresses a critical gap in the treatment of complex Post-Traumatic Stress Disorder (PTSD) and "moral injury" among survivors of sexual violence. Moral injury refers to the profound psychological distress that occurs when an individual experiences or witnesses actions that transgress deeply held moral beliefs and expectations.
Standard therapeutic approaches, such as Prolonged Exposure (PE) or Eye Movement Desensitization and Reprocessing (EMDR), often rely on a patient's ability to mentally visualize their trauma or engage in an internal "confrontation" with the perpetrator. However, for many survivors, severe avoidance symptoms or the nature of the moral injury make this visualization extremely difficult. The study sought to overcome these barriers by utilizing generative AI to create a more tangible therapeutic experience.
Technological Innovation: Deepfakes in Virtual Reality
The study explored the use of deepfake technology to generate realistic, controllable digital likenesses of perpetrators. These avatars were then integrated into a Virtual Reality (VR) environment, allowing for a structured and immersive therapeutic encounter. By providing a visual and auditory representation of the perpetrator, the technology aims to facilitate the emotional processing required for recovery in a way that traditional mental imagery might not.
This application represents a significant shift in the use of deepfakes—a technology frequently associated with misinformation—positioning it instead as a sophisticated clinical tool for psychological healing.
The Corrigendum: Disclosure of Commercial Interests
The most significant update provided by this corrigendum is the disclosure of commercial ties between the authors and the technology used in the study. It has been clarified that:
- Theo Gevers (TG) and Sezer Karaoglu (SK) are co-founders of 3DUniversum, an Amsterdam-based company specializing in 3D computer vision and deep learning.
- Sezer Karaoglu (SK) is also an employee of 3DUniversum.
While the authors maintain that the scientific findings regarding the development and initial testing of the deepfake tool remain unchanged, this disclosure is vital for maintaining transparency in MedTech research. The remaining authors (van Minnen, ter Heide, Koolstra, and de Jongh) have declared no competing financial or commercial interests.
Implications for Research Integrity and Future Work
This correction highlights the ethical necessity of disclosing when the developers of a technology are also the ones evaluating its clinical efficacy. In fields like psychiatry, where researcher bias can influence outcomes, such transparency is essential for the objective validation of new treatments.
Limitations
The reliance on proprietary technology from 3DUniversum may limit the ability of independent researchers to replicate the study's findings. Future research in this domain should focus on:
- Independent Replication: Testing the efficacy of deepfake-assisted therapy through teams with no financial ties to the software developers.
- Ethical Frameworks: Developing rigorous guidelines for the creation of perpetrator likenesses to ensure the technology is used safely and does not cause further trauma to the victims.
Conclusion
Despite the initial reporting error, the development of deepfake-assisted perpetrator confrontation remains a promising frontier in trauma therapy. This corrigendum ensures that the scientific record accurately reflects the commercial context of the research, allowing the academic community to better evaluate the study's contributions to the field of clinical psychology.
Summary updated